Informations sur le produit
GZD 824 is a receptor molecule that competes with the receptor for the protein ubiquitin. GZD 824 binds to the ubiquitin-binding site and prevents ubiquitin from binding, thereby inhibiting the proteasome pathway. This leads to an accumulation of cellular proteins and activation of signal pathways, which may be useful in treating cancer and autoimmune diseases. GZD 824 has also been shown to bind to multikinase enzymes such as bcr-abl, which are important in signaling pathways. GZD 824 may have potential as a treatment for infectious diseases by activating molecular responses that are associated with these diseases.